157 related articles for article (PubMed ID: 8091396)
1. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice.
Pierangeli SS; Barker JH; Stikovac D; Ackerman D; Anderson G; Barquinero J; Acland R; Harris EN
Thromb Haemost; 1994 May; 71(5):670-4. PubMed ID: 8091396
[TBL] [Abstract][Full Text] [Related]
2. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome.
Pierangeli SS; Liu XW; Barker JH; Anderson G; Harris EN
Thromb Haemost; 1995 Nov; 74(5):1361-7. PubMed ID: 8607123
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models.
Pierangeli SS; Liu X; Espinola R; Olee T; Zhu M; Harris NE; Chen PP
Thromb Haemost; 2000 Sep; 84(3):388-95. PubMed ID: 11019960
[TBL] [Abstract][Full Text] [Related]
6. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
[TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis.
Amitrano L; Ames PR; Guardascione MA; Lopez LR; Menchise A; Brancaccio V; Iannaccone L; Balzano A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):367-70. PubMed ID: 20530055
[TBL] [Abstract][Full Text] [Related]
11. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.
Carrera-Marín A; Romay-Penabad Z; Papalardo E; Reyes-Maldonado E; García-Latorre E; Vargas G; Shilagard T; Pierangeli S
Lupus; 2012 Dec; 21(14):1497-505. PubMed ID: 22933620
[TBL] [Abstract][Full Text] [Related]
12. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
14. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies in an in vivo thrombosis model in mice.
Pierangeli SS; Harris EN
Lupus; 1994 Aug; 3(4):247-51. PubMed ID: 7804310
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
Pierangeli SS; Vega-Ostertag ME; Raschi E; Liu X; Romay-Penabad Z; De Micheli V; Galli M; Moia M; Tincani A; Borghi MO; Nguyen-Oghalai T; Meroni PL
Ann Rheum Dis; 2007 Oct; 66(10):1327-33. PubMed ID: 17261530
[TBL] [Abstract][Full Text] [Related]
17. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
[TBL] [Abstract][Full Text] [Related]
18. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies.
Blank M; Tincani A; Shoenfeld Y
J Rheumatol; 1994 Jan; 21(1):100-4. PubMed ID: 8151562
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies.
George J; Afek A; Gilburd B; Levy Y; Blank M; Kopolovic J; Harats D; Shoenfeld Y
Lupus; 1997; 6(9):723-9. PubMed ID: 9412988
[TBL] [Abstract][Full Text] [Related]
20. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies.
Pierangeli SS; Liu SW; Anderson G; Barker JH; Harris EN
Circulation; 1996 Oct; 94(7):1746-51. PubMed ID: 8840870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
